Altium Capital Management LP Neuronetics, Inc. Transaction History

Altium Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.22 - $15.54 $1.15 Million - $2.87 Million	-184,554 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$10.15 - $17.25 $477,598 - $811,681	47,054 Added 34.22%	184,554 $2.96 Million
Q1 2021 May 06, 2021	BUY	$10.6 - $21.27 $1.46 Million - $2.92 Million	137,500 New	137,500 $1.7 Million

13M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $63.2M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.